162 related articles for article (PubMed ID: 14643638)
1. Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections.
Gérard HC; Whittum-Hudson JA; Schumacher HR; Hudson AP
Microb Pathog; 2004 Jan; 36(1):35-9. PubMed ID: 14643638
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.
Gérard HC; Freise J; Wang Z; Roberts G; Rudy D; Krauss-Opatz B; Köhler L; Zeidler H; Schumacher HR; Whittum-Hudson JA; Hudson AP
Microbes Infect; 2002 Jan; 4(1):13-22. PubMed ID: 11825770
[TBL] [Abstract][Full Text] [Related]
3. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression.
Gérard HC; Branigan PJ; Schumacher HR; Hudson AP
J Rheumatol; 1998 Apr; 25(4):734-42. PubMed ID: 9558178
[TBL] [Abstract][Full Text] [Related]
4. Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection.
Gérard HC; Krausse-Opatz B; Wang Z; Rudy D; Rao JP; Zeidler H; Schumacher HR; Whittum-Hudson JA; Köhler L; Hudson AP
Mol Microbiol; 2001 Aug; 41(3):731-41. PubMed ID: 11532140
[TBL] [Abstract][Full Text] [Related]
5. Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes.
Gérard HC; Köhler L; Branigan PJ; Zeidler H; Schumacher HR; Hudson AP
Med Microbiol Immunol; 1998 Oct; 187(2):115-20. PubMed ID: 9832326
[TBL] [Abstract][Full Text] [Related]
6. Synovial Chlamydia trachomatis up regulates expression of a panel of genes similar to that transcribed by Mycobacterium tuberculosis during persistent infection.
Gérard HC; Whittum-Hudson JA; Schumacher HR; Hudson AP
Ann Rheum Dis; 2006 Mar; 65(3):321-7. PubMed ID: 16192289
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.
Deka S; Vanover J; Dessus-Babus S; Whittimore J; Howett MK; Wyrick PB; Schoborg RV
Cell Microbiol; 2006 Jan; 8(1):149-62. PubMed ID: 16367874
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis.
Gérard HC; Carter JD; Hudson AP
Am J Med Sci; 2013 Jul; 346(1):22-5. PubMed ID: 23792903
[TBL] [Abstract][Full Text] [Related]
9. The role of Chlamydia and Chlamydophila infections in reactive arthritis.
Rizzo A; Domenico MD; Carratelli CR; Paolillo R
Intern Med; 2012; 51(1):113-7. PubMed ID: 22214635
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia trachomatis: the Persistent Pathogen.
Witkin SS; Minis E; Athanasiou A; Leizer J; Linhares IM
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28835360
[No Abstract] [Full Text] [Related]
11. Differential expression of groEL-1, incB, pyk-F, tal, hctA and omcB genes during Chlamydia trachomatis developmental cycle.
Mzobe GF; Ngcapu S; Joubert BC; Sturm WA
PLoS One; 2021; 16(4):e0249358. PubMed ID: 33857160
[TBL] [Abstract][Full Text] [Related]
12. Analysis of modulated gene expression in a model of Interferon-gamma-induced persistence of Chlamydia trachomatis in HEp-2 cells.
Kokab A; Jennings R; Eley A; Pacey AA; Cross NA
Microb Pathog; 2010 Nov; 49(5):217-25. PubMed ID: 20558272
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of the products of GROEL-1 gene from Chlamydia trachomatis serovar D and the HSP60 var1 transcript from Homo sapiens suggests a possible autoimmune response.
Campanella C; Marino Gammazza A; Mularoni L; Cappello F; Zummo G; Di Felice V
Int J Immunogenet; 2009 Feb; 36(1):73-8. PubMed ID: 19207939
[TBL] [Abstract][Full Text] [Related]
14. Cervical epithelial cells from Chlamydia trachomatis-infected sites coexpress higher levels of chlamydial heat shock proteins 60 and 10 in infertile women than in fertile women.
Jha R; Vardhan H; Bas S; Salhan S; Mittal A
Gynecol Obstet Invest; 2009; 68(3):160-6. PubMed ID: 19641324
[TBL] [Abstract][Full Text] [Related]
15. Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2.
Kiselev AO; Skinner MC; Lampe MF
PLoS One; 2009; 4(4):e5191. PubMed ID: 19367336
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes.
Koehler L; Nettelnbreker E; Hudson AP; Ott N; Gérard HC; Branigan PJ; Schumacher HR; Drommer W; Zeidler H
Microb Pathog; 1997 Mar; 22(3):133-42. PubMed ID: 9075216
[TBL] [Abstract][Full Text] [Related]
17. Persistent Chlamydia trachomatis infection: in vitro phenomenon or in vivo trigger of reactive arthritis?
Morrison RP
J Rheumatol; 1998 Apr; 25(4):610-2. PubMed ID: 9558158
[No Abstract] [Full Text] [Related]
18. Persistent infection of Chlamydia in reactive arthritis.
Rihl M; Köhler L; Klos A; Zeidler H
Ann Rheum Dis; 2006 Mar; 65(3):281-4. PubMed ID: 16474031
[TBL] [Abstract][Full Text] [Related]
19. Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells.
Marangoni A; Zalambani C; Marziali G; Salvo M; Fato R; Foschi C; Re MC
Microb Pathog; 2020 Oct; 147():104347. PubMed ID: 32561420
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia and chronic arthritis.
Carter JD; Inman RD; Whittum-Hudson J; Hudson AP
Ann Med; 2012 Dec; 44(8):784-92. PubMed ID: 21864020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
